Transforming growth factor-β 1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors

Pediatric Nephrology

Volumn 19, Issue 12, 2004, Pages 1349-1353

  Wasilewska, Anna M ^a   Zoch Zwierz, Walentyna M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cyclosporin; Nephrotic syndrome; Transforming growth factor 1; Urine

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISONE; STEROID; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOCAL GLOMERULOSCLEROSIS; HUMAN; MALE; MEDICAL ASSESSMENT; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; TREATMENT OUTCOME;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; HUMANS; MALE; NEPHROTIC SYNDROME; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 8844249963     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1619-5     Document Type: Article

References (25)

1. Takeda A, Ohgushi H, Niimura F, Matsutani H (1998) Long-term effects of immunosuppressant in steroid dependent nephrotic syndrome. Pediatr Nephrol 12:746-750 10.1007/s004670050538, 1:STN:280:DyaK1M%2FovFOitw%3D%3D, 9874319
2. Khanna AK, Caims VR, Becker CG, Hosenpud JD (1998) TGF-β: A link between immunosuppression, nephrotoxicity and CsA. Transplant Proc 30:944-945 10.1016/S0041-1345(98)00102-X, 1:CAS:528:DyaK1cXktF2hu7g%3D, 9636380
3. Seikaly MG, Prashner H, Nolde-Hurlbert B, Browne R (2000) Long-term clinical and pathological effects of cyclosporin in children with nephrosis. Pediatr Nephrol 14:214-217
4. Sairam VK, Kalia A, Rajaraman S, Travis LB (2002) Secondary resistance to cyclosporin A in children with nephrotic syndrome. Pediatr Nephrol 17:842-846 10.1007/s00467-002-0896-0, 12376814
5. Chishti AS, Sorof JM, Eileen D, Brever ED, Kale AS (2001) Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 38:754-760 1:CAS:528:DC%2BD3MXnslKgs7w%3D, 11576878
6. Yayama K, Makino J, Takano M, Okamoto H (1995) Role of angiotensin II in the transforming growth factor-beta 1 expression of rat kidney in anti-glomerular basement membrane antiserum-induced glomerulonephritis. Biol Pharm Bull 18:687-690 1:CAS:528:DyaK2MXnsVajtrc%3D, 7492983
7. Ruiz-Ortega M, Egido J (1997) Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblast. Kidney Int 52:1497-1499 1:CAS:528:DyaK2sXotVKgtLY%3D, 9407495
8. Branton MH, Kopp JB (1999) TGF-β and fibrosis. Microbes Infect 1:1349-1365 10.1016/S1286-4579(99)00250-6, 1:CAS:528:DC%2BD3cXjtFehsbk%3D, 10611762
9. Khalil A, Tullus K, Bakhiet M, Burman LG, Jaremko G, Brauner A (2000) Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis. J Urol 164:186-191 10.1097/00005392-200007000-00058, 1:CAS:528:DC%2BD3cXksVCkurc%3D, 10840457
10. Goumenos DS, Tsamandas AC, Oldroyd S, Sotsiou F, Tsakas S, Petropoulou C, Bonikos D, El Nahas AM, Vlachojannis JG (2001) Transforming growth factor-β1 in kidney and urine of patients with glomerular disease and proteinuria. Nephron 87:240-248 10.1159/000045921, 1:CAS:528:DC%2BD3MXivVajsLg%3D, 11287759
11. Taniguchi Y, Yorioka N, Masaki T, Yamashita K, Ito T, Ueda H, Yamakido M (2000) Role of transforming growth factor-beta 1 in glomerulonephritis. J Int Med Res 25:71-80
12. Schiffer M, Von Gersdorff G, Bitzer M, Susztak K, Bottinger EP (2000) S-mad proteins and transforming growth factor-beta signaling. Kidney Int 58:45-52 10.1046/j.1523-1755.2000.07708.x
13. Honkanen E, Teppo AM, Törnroth T, Groop PH, Grönhagen-Riska C (1997) Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant 12:2562-2768 10.1093/ndt/12.12.2562, 1:STN:280:DyaK1c%2Fpt1OhsQ%3D%3D, 9430852
14. Ito Y, Goldschmeding R, Bende R, Claessen N, Chand M, Kleij L, Rabelink T, Weening J, Aten J (2001) Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 12:472-484 1:CAS:528:DC%2BD3MXitV2ksbY%3D, 11181795
15. Okuda S, Languino LR, Ruoslahti E, Border WA (1990) Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462 1:CAS:528:DyaK3cXltlSnsLs%3D, 2200803
16. Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, Kooten C van, Muller G (2001) TGF-β1 induced proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 59:579-592 10.1046/j.1523-1755.2001.059002579.x, 1:CAS:528:DC%2BD3MXhtlKisb4%3D, 11168939
17. Shin GT, Kim SJ, Ma KA, Kim HS, Kim D (2000) ACE inhibitors attenuate expression of renal transforming growth factor-beta in humans. Am J Kidney Dis 36:894-902 1:CAS:528:DC%2BD3cXot1Wntr4%3D, 11054345
18. Monteiro de Freitas AS, Coimbra TM, Costa RS, Baroni EA (1998) Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtotal renal ablation: Effect of enalapril and nifedipine. Nephron 78:302-309 10.1159/000044940, 9546691
19. Burton C, Harris KPS (1996) The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 27:765-775
20. Senatorski G, Paczek L, Sulowicz W, Gradowski L, Bartlomiejczyk I (1998) Urine activity of cathepsin B, collagenase and urine excretion of TGF-β1 and fibronectin in membranous glomerulonephritis. Res Exp Med 198:199-206 10.1007/s004330050103, 1:CAS:528:DyaK1MXht1Knug%3D%3D
21. Kanai H, Mitsuhashi H, Ono K, Yano S, Naruse T (1994) Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis. Nephron 66:391-395 1:STN:280:ByuB1cngsVI%3D, 8015640
22. Murakami K, Takemura T, Hino S, Yoshioka K (1997) Urinary transforming growth factor-β in patients with glomerular diseases. Pediatr Nephrol 11:334-336 10.1007/s004670050289, 1:STN:280:ByiA2cnns1w%3D, 9203185
23. De Muro P, Faedda R, Fresu P, Masala A, Cigni A, Concas G, Mela MG, Satta A Carcassi A, Sanna GM, Cherchi GM (2004) Urinary transforming growth factor-beta 1 in various types of nephropathy. Pharmacol Res 49:293-298 10.1016/j.phrs.2003.10.003, 14726227
24. Stabellini G, Carinci F, Luigi Bedani P, Calastrini C, De Mattei M, Scapoli L, Caruso A, Calvitti M, Locci P (2002) Cyclosporin A and transforming growth factor beta modify the pattern of extracellular glycosaminoglycans without causing cytoskeletal changes in human gingival fibroblasts. Transplantation 73:1676-1679 10.1097/00007890-200205270-00026, 1:CAS:528:DC%2BD38XkvFGmurg%3D, 12042659
25. Böhler T, Budde K, Schneider M, Eliazyfer S, Dell K, Einecke G, Diekmann F, Fritsche L, Mai I, Neumayer HH, Waiser J (2001) Pharmacodynamic monitoring of lymphocyte proliferation and TGF-β1 expression at cyclosporine A (CyA) trough levels (Co) and 2 hours after intake (C2) of CyA in human renal allograft recipients. Transplant Proc 33:3148-3150 10.1016/S0041-1345(01)02341-7, 11750352